Abstract
Phase 1/2 trial of Pb-212-VMT-alpha-NET in GI neuroendocrine tumors and pheochromocytoma/paraganglioma previously treated with radioligand therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have